心泰医疗(02291.HK)ScienCrown主动脉瓣膜系统取得医疗器械登记证

阿斯达克财经
18 Dec 2024

心泰医疗(02291.HK) 公布,中国国家药品监督管理局已授出ScienCrow经导管植入式主动脉瓣膜系统产品的医疗器械登记证。公司的ScienCrown经导管植入式主动脉瓣膜系统结构设计从临床实际出发,有效解决TAVR术中瓣膜扩张不良、移位风险、冠状动脉阻塞等现存难点,并具备多项专利。(de/d)(港股报价延迟最少十五分钟。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10